Skip to main content
SpringerLink
Log in

Advances in pharmacologic agents in imaging: New A2A receptor agonists

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Pharmacologic stress myocardial perfusion imaging is being performed with increasing frequency over exercise stress. Dipyridamole and adenosine have a high side-effect profile, provide higher than needed coronary artery flow rates, and use a relatively complicated method of administration. Based on preclinical animal work, three selective adenosine A2A receptor agonists, regadenoson (CVT3146), binodenoson (MRE0470 or WRC0470), and apadenoson (BMS068645 or ATL146e), may overcome these limitations and are now in Phase III studies as pharmacologic stress agents. For single-photon emission CT imaging, binodenoson and regadenoson were concordant with adenosine images for detection and quantitation of ischemia. Despite the high A2A selectivity of binodenoson and regadenoson in preclinical studies, subjective side effects attributable to other adenosine receptor subtypes were still observed in human studies and are similar to or slightly lower than adenosine. There have been no reports of atrioventricular block or bronchospasm with either regadenoson or binodenoson in published trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Cerqueira MD, Verani MS, Schwaiger M, et al.: Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 1994, 23:384–389.

    Article  PubMed  CAS  Google Scholar 

  2. Ranhosky A, Kempthorne-Rawson J: The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group. Circulation 1990, 81:1205–1209.

    PubMed  CAS  Google Scholar 

  3. Hendel RC, Jamil T, Glover DK: Pharmacologic stress testing: new methods and new agents. J Nucl Cardiol 2003, 10:197–204.

    Article  PubMed  Google Scholar 

  4. Iskandrian AS, Verani MS, Heo J: Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease. J Nucl Cardiol 1994, 1:94–111.

    Article  PubMed  CAS  Google Scholar 

  5. Travain MI, Wexler JP: Pharmacological stress testing. Semin Nucl Med 1999, 29:298–318.

    Article  PubMed  CAS  Google Scholar 

  6. Cerqueira MD: The future of pharmacologic stress: selective A2A adenosine receptor agonists. Am J Cardiol 2004, 94:33D-40D; discussion 40D–42D.

    Article  PubMed  CAS  Google Scholar 

  7. Shryock JC, Snowdy S, Baraldi PG, et al.: A2A-adenosine receptor reserve for coronary vasodilation. Circulation 1998, 98:711–718.

    PubMed  CAS  Google Scholar 

  8. Trochu JN, Zhao G, Post H, et al.: Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs: potential for use in myocardial perfusion imaging. J Cardiovasc Pharmacol 2003, 41:132–139.

    Article  PubMed  CAS  Google Scholar 

  9. Gao Z, Li Z, Baker SP, et al.: Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists. J Pharmacol Exp Ther 2001, 298:209–218.

    PubMed  CAS  Google Scholar 

  10. Zhao G, Linke A, Xu X, et al.: Comparative profile of vasodilation by CVT-3146, a novel A2A receptor agonist, and adenosine in conscious dogs. J Pharmacol Exp Ther 2003, 307:182–189.

    Article  PubMed  CAS  Google Scholar 

  11. Glover DK, Ruiz M, Yang JY, et al.: Pharmacological stress thallium scintigraphy with 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470). A novel, short-acting adenosine A2A receptor agonist. Circulation 1996, 94:1726–1732.

    PubMed  CAS  Google Scholar 

  12. Kern M, Hodgson J, Rossen J, et al.: Hyperemic coronary blood flow induced by a selective adenosine A2A receptor stimulation: first report in patients of a well-tolerated novel agent for stress imaging. Abstract. J Am Coll Cardiol 2001, 37(Suppl A):299A.

    Google Scholar 

  13. Udelson JE, Heller GV, Wackers FJ, et al.: Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation 2004, 109:457–464. First and largest clinical trial looking at safety and efficacy of A2A-selective agents.

    Article  PubMed  CAS  Google Scholar 

  14. Kerensky R, von Mering G, Kent K, et al.: Dose dependent increase in human coronary blood flow velocity following an IV bolus of CVT-3146, a novel A2A adenosine receptor agonist: a potential agent for the use in pharmacological stress testing for myocardial perfusion imaging [abstract]. Circulation 2002, 106:II-618.

    Google Scholar 

  15. Hendel RC, Bateman TM, Cerqueira MD, et al.: Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 2005, 46:2069–2075. First trial on A2A-selective agents given as a rapid bolus at a fixed dose. Showed preliminary safety and efficacy in a small trial.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular and Functional Imaging (Gb3), Cleveland Clinic Foundation, 9500 Euclid Avenue, 44195, Cleveland, OH, USA

    Manuel D. Cerqueira MD

Authors
  1. Manuel D. Cerqueira MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manuel D. Cerqueira MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cerqueira, M.D. Advances in pharmacologic agents in imaging: New A2A receptor agonists. Curr Cardiol Rep 8, 119–122 (2006). https://doi.org/10.1007/s11886-006-0022-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-006-0022-1

Keywords

Search

Navigation